NCT03723447View on ClinicalTrials.gov

Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

October 23, 2018

Primary Completion Date

October 29, 2019

Study Completion Date

October 29, 2019

Conditions
Pain, PostoperativeCrohn DiseaseInflammatory Bowel DiseasesColorectal CancerGastrointestinal CancerGastrointestinal DiseaseDigestive System DiseasePainPain, NeuropathicIntestinal Disease
Interventions
DRUG

Liposomal bupivacaine

Liposomal bupivacaine will be given during the bilateral laparoscopic-guided TAP block given to each patient intraoperatively.

DRUG

Bupivacaine/epinephrine/dexamethasone

Bupivacaine/epinephrine/dexamethasone will be given during the bilateral laparoscopic-guided TAP block administered to each patient intraoperatively.

Trial Locations (1)

90048

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT03723447 - Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) | Biotech Hunter | Biotech Hunter